IMS-5 Checkup

US$2,430
NT$78,000 · you pay the hospital in NT$
Book this checkup

Prefer to book it yourself? Call Mackay Memorial Hospital on +886-2-2543-3535 (ext. 3370, 3380) or use its English site ↗. It's free; most hospitals take bookings in Chinese.

We book it with the hospital for you, from US$149, paid only after the hospital confirms. We reply by email with available dates, the confirmed price, and whether an English report is available.

Paying from a US account? HSA and FSA notes.

Share on LINE / 分享到 LINE

As published by the hospital · checked 2026-09-20

A premium-tier program with Abdominal MRI / MRCP, Brain MRI, Chest CT (standard dose), Abdominal ultrasound and Breast ultrasound and a 67-test panel, with a doctor's review at the end.

Sedation
Available, US$467 (NT$15,000) extra
Lead time
7 days
English report
Ask the hospital (we ask for you in Book it for me)

What stands out

Abdominal MRI / MRCP

Liver, pancreas and bile duct tumors and disease.

Brain MRI

Brain tumors, small strokes, aneurysms and early degeneration.

Chest CT (standard dose)

Detailed lung and chest imaging.

Abdominal ultrasound

Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.

Every test, in English

67 tests listed, 64 of them on our shared test list, so they line up against other hospitals' packages.

Vitals4
Blood Count3
Liver Function9
Kidney & Electrolytes3
Lipids & Cardiometabolic5
Glucose2
Thyroid & Endocrine5
Tumor Markers6
Infection Serology4
Urine & Stool1
Cardiac4
X-ray3
Ultrasound6
CT Imaging1
MRI Imaging2
Women's Health1
Bone & Body Composition1
ENT & Dental2
Consultation2
Show all 67 tests and what each screens for
TestScreens for
Vitals
Blood pressureScreens for hypertension, a major risk factor for heart disease and stroke.
Body composition analysisBody fat, muscle mass and water percentage.
Height, weight and BMIBasic body measurements used to assess weight-related health risk.
Waist circumferenceCentral obesity, a marker of metabolic risk.
Blood Count
Complete blood countAnemia, infection and blood cell disorders.
Coagulation panelHow well your blood clots.
White blood cell differentialBreakdown of white cell types; infection, allergy and some blood cancers.
Liver Function
Alkaline phosphataseLiver, bile duct and bone conditions.
ALT (SGPT)Liver cell damage; the most common liver screening test.
AmylasePancreatic or salivary gland enzyme; elevated levels can indicate pancreatitis.
AST (SGOT)Liver cell damage.
Direct bilirubinBile duct obstruction.
Gamma-GTBile duct and alcohol-related liver stress.
Globulin and A/G ratioImmune protein levels.
Lactate dehydrogenaseNon-specific tissue damage marker.
Total bilirubinJaundice, liver and bile problems.
Kidney & Electrolytes
Blood urea nitrogenKidney function.
CreatinineKidney function.
Uric acidGout risk and kidney stone risk.
Lipids & Cardiometabolic
HDL cholesterolProtective cholesterol level.
HomocysteineCardiovascular risk marker.
LDL cholesterolThe main cholesterol driving heart disease risk.
Total cholesterolCardiovascular risk.
TriglyceridesCardiovascular and pancreatitis risk.
Glucose
Fasting glucoseDiabetes and prediabetes.
Hemoglobin A1cAverage blood sugar over the past three months; diabetes.
Thyroid & Endocrine
CortisolAdrenal stress hormone.
Free T4Thyroid hormone level.
T3Thyroid hormone level.
TSHThyroid function; the primary thyroid screening test.
Vitamin D (25-OH)Vitamin D deficiency; bone health.
Tumor Markers
AFPLiver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA 19-9Pancreatic and biliary cancer marker.
CEAColorectal and other GI cancer marker.
EBV VCA-IgANasopharyngeal cancer risk (common in Taiwan and southern China).
Free PSA ratioRefines prostate cancer risk when PSA is borderline.
PSAProstate cancer marker.
Infection Serology
Hepatitis B core antibodyPast or hidden hepatitis B exposure.
Hepatitis B surface antibodyImmunity to hepatitis B (from vaccine or past infection).
Hepatitis C antibodyHepatitis C infection.
Hepatitis B surface antigenCurrent hepatitis B infection; very common in Taiwan.
Urine & Stool
UrinalysisKidney disease, urinary infection, diabetes.
Cardiac
Arterial stiffness (ABI / PWV)Peripheral artery disease and arterial stiffness.
Creatine kinaseMuscle and heart muscle damage.
EchocardiogramHeart structure, valves and pumping function.
Resting ECGHeart rhythm and signs of prior heart damage.
X-ray
Abdominal X-ray (KUB)Kidney stones and bowel abnormalities.
Chest X-rayLung, heart size and chest abnormalities.
Spine X-rayDegeneration and alignment of the spine.
Ultrasound
Abdominal ultrasoundLiver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Breast ultrasoundBreast lumps; complements mammography, especially in dense breasts.
Kidney and bladder ultrasoundKidney stones, cysts, bladder abnormalities.
Pelvic (gynecologic) ultrasoundUterus and ovary abnormalities (fibroids, cysts).
Prostate ultrasoundProstate size and abnormalities.
Thyroid ultrasoundThyroid nodules.
CT Imaging
Chest CT (standard dose)Detailed lung and chest imaging.
MRI Imaging
Abdominal MRI / MRCPLiver, pancreas and bile duct tumors and disease.
Brain MRIBrain tumors, small strokes, aneurysms and early degeneration.
Women's Health
Pap smearCervical cancer and precancer.
Bone & Body Composition
Bone density (DXA)Osteoporosis and fracture risk.
ENT & Dental
Hearing testHearing loss.
ENT examinationEar, nose and throat abnormalities.
Consultation
Physician physical examinationA doctor's hands-on examination and history taking.
Physician consultation and report reviewA doctor explains your results and what to do next.
Vitals
Blood pressure
Screens for hypertension, a major risk factor for heart disease and stroke.
Body composition analysis
Body fat, muscle mass and water percentage.
Height, weight and BMI
Basic body measurements used to assess weight-related health risk.
Waist circumference
Central obesity, a marker of metabolic risk.
Blood Count
Complete blood count
Anemia, infection and blood cell disorders.
Coagulation panel
How well your blood clots.
White blood cell differential
Breakdown of white cell types; infection, allergy and some blood cancers.
Liver Function
Alkaline phosphatase
Liver, bile duct and bone conditions.
ALT (SGPT)
Liver cell damage; the most common liver screening test.
Amylase
Pancreatic or salivary gland enzyme; elevated levels can indicate pancreatitis.
AST (SGOT)
Liver cell damage.
Direct bilirubin
Bile duct obstruction.
Gamma-GT
Bile duct and alcohol-related liver stress.
Globulin and A/G ratio
Immune protein levels.
Lactate dehydrogenase
Non-specific tissue damage marker.
Total bilirubin
Jaundice, liver and bile problems.
Kidney & Electrolytes
Blood urea nitrogen
Kidney function.
Creatinine
Kidney function.
Uric acid
Gout risk and kidney stone risk.
Lipids & Cardiometabolic
HDL cholesterol
Protective cholesterol level.
Homocysteine
Cardiovascular risk marker.
LDL cholesterol
The main cholesterol driving heart disease risk.
Total cholesterol
Cardiovascular risk.
Triglycerides
Cardiovascular and pancreatitis risk.
Glucose
Fasting glucose
Diabetes and prediabetes.
Hemoglobin A1c
Average blood sugar over the past three months; diabetes.
Thyroid & Endocrine
Cortisol
Adrenal stress hormone.
Free T4
Thyroid hormone level.
T3
Thyroid hormone level.
TSH
Thyroid function; the primary thyroid screening test.
Vitamin D (25-OH)
Vitamin D deficiency; bone health.
Tumor Markers
AFP
Liver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA 19-9
Pancreatic and biliary cancer marker.
CEA
Colorectal and other GI cancer marker.
EBV VCA-IgA
Nasopharyngeal cancer risk (common in Taiwan and southern China).
Free PSA ratio
Refines prostate cancer risk when PSA is borderline.
PSA
Prostate cancer marker.
Infection Serology
Hepatitis B core antibody
Past or hidden hepatitis B exposure.
Hepatitis B surface antibody
Immunity to hepatitis B (from vaccine or past infection).
Hepatitis C antibody
Hepatitis C infection.
Hepatitis B surface antigen
Current hepatitis B infection; very common in Taiwan.
Urine & Stool
Urinalysis
Kidney disease, urinary infection, diabetes.
Cardiac
Arterial stiffness (ABI / PWV)
Peripheral artery disease and arterial stiffness.
Creatine kinase
Muscle and heart muscle damage.
Echocardiogram
Heart structure, valves and pumping function.
Resting ECG
Heart rhythm and signs of prior heart damage.
X-ray
Abdominal X-ray (KUB)
Kidney stones and bowel abnormalities.
Chest X-ray
Lung, heart size and chest abnormalities.
Spine X-ray
Degeneration and alignment of the spine.
Ultrasound
Abdominal ultrasound
Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Breast ultrasound
Breast lumps; complements mammography, especially in dense breasts.
Kidney and bladder ultrasound
Kidney stones, cysts, bladder abnormalities.
Pelvic (gynecologic) ultrasound
Uterus and ovary abnormalities (fibroids, cysts).
Prostate ultrasound
Prostate size and abnormalities.
Thyroid ultrasound
Thyroid nodules.
CT Imaging
Chest CT (standard dose)
Detailed lung and chest imaging.
MRI Imaging
Abdominal MRI / MRCP
Liver, pancreas and bile duct tumors and disease.
Brain MRI
Brain tumors, small strokes, aneurysms and early degeneration.
Women's Health
Pap smear
Cervical cancer and precancer.
Bone & Body Composition
Bone density (DXA)
Osteoporosis and fracture risk.
ENT & Dental
Hearing test
Hearing loss.
ENT examination
Ear, nose and throat abnormalities.
Consultation
Physician physical examination
A doctor's hands-on examination and history taking.
Physician consultation and report review
A doctor explains your results and what to do next.
Also listed: Attending internist same-day report review, Pulse, Urology consultation.

Before you book

SedationAvailable, US$467 (NT$15,000) extra
Booking lead time7 days
If something is foundAsk the hospital how any findings are explained, on the day or at a follow-up appointment; in Book it for me we ask for you and tell you before you book. Your own doctor decides what to do next; we do not arrange treatment.
Results and imagingAsk the hospital how long results take and how imaging is delivered; in Book it for me we ask for you and tell you before you book.
Mackay Memorial Hospital Health Examination Center
Medical center
Taipei · Zhongshan

About 3 minutes' walk (213 m) from Shuanglian station

On the OCAC i僑卡 partner list. Card holders can ask the center about a discount.

6 packages listed

About this hospital

What the center says

From the center's own pages, in English. Each statement links to its source.

Booking and payment
  • The center asks visitors to complete their booking at least 7 working days before the checkup so it can arrange a suitable package and physician.

    Source ↗ · checked 2026-09-20

  • The center offers communication service in Chinese, English and other languages, with an international patient consultation window for overseas visitors arranging video assessments and follow-up visits.

    Source ↗ · checked 2026-09-20

  • The center has an international patient consultation window so overseas visitors can arrange video assessments and follow-up visits.

    Source ↗ · checked 2026-09-20

Results
  • On the day of the checkup, the attending internal-medicine physician can explain most of the report.

    Source ↗ · checked 2026-09-20

  • The center's checkup process runs from booking through the exam to a report explanation and health consultation, with a staff member assisting throughout.

    Source ↗ · checked 2026-09-20

US price context

Bought one by one at US cash-pay marketplaces, the tests we could price list at about US$5,420–7,547 for a woman (60 of 61 tests) and US$5,572–7,599 for a man (60 of 61 tests) (MDsave, Quest and others; checked 2026-10-11).

How we priced it

A panel counts once however many of its tests the package lists. A test for one sex only is counted only for that sex. Tests we could not price are left out, so this is not what a US checkup would cost. Prices marked "rough" come from a single reseller or are extrapolated from a similar test.

Radiation from this package's imaging

About 8.3 mSv from the tests we could identify, a typical adult dose for these exams: roughly 2.8 years of natural background radiation (about 3 mSv a year, US average).

This package also lists 3 items we have not matched to a test; if any of them is an X-ray, CT or PET scan, the total is higher.

  • Abdominal X-ray (KUB) · about 0.7 mSv
  • Bone density (DXA) · about less than 0.01 mSv
  • Chest X-ray · about 0.1 mSv
  • Chest CT (standard dose) · about 6.1 mSv
  • Spine X-ray · about 1.4 mSv

Typical doses from published references (RadiologyInfo.org ↗, Mettler et al. 2008 ↗); the actual dose depends on the scanner and protocol. Ask the center for its own figure.

What US screening guidelines say

The US Preventive Services Task Force is an independent US panel whose recommendations cover people without symptoms. Shown for comparison; it is not advice for you.

What US screening guidelines say about 24 of these tests
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding the ankle-brachial index to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF lists an update in progress for this statement that is limited to coronary artery calcium scoring; its September 2024 research plan excludes the ABI, which it says will be evaluated as a screening test in a separate future topic on peripheral artery disease.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for peripheral artery disease and cardiovascular disease risk with the ankle-brachial index in asymptomatic adults. (2018) · USPSTF ↗ Note: A separate statement from the nontraditional-risk-factor one; see the other abi_pwv row. Neither USPSTF statement mapped here addresses pulse wave velocity (arterial stiffness).
Recommended (grade A/B)The USPSTF recommends screening all adults aged 18 to 79 years for hepatitis C virus infection. (2020) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for hearing loss in adults 50 years or older. (2021) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for hypertension in adults 18 years or older with office blood pressure measurement, confirmed with measurement outside the clinical setting before starting treatment. (2021) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in postmenopausal women younger than 65 years who are at increased risk, based on a clinical risk-assessment tool. (2025) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for osteoporosis in men. (2025) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in women 65 years or older. (2025) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of supplemental screening with breast ultrasound in women found to have dense breasts on an otherwise negative screening mammogram. (2024) · USPSTF ↗ Note: Same I statement covers ultrasound and MRI as supplemental tests; see mri_breast. The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Recommended against (grade D)The USPSTF recommends against screening for pancreatic cancer in asymptomatic average-risk adults. (2019) · USPSTF ↗ Note: The recommendation states there are currently no accurate, validated biomarkers for early detection of pancreatic cancer and that the USPSTF does not recommend screening the general population by any method; it does not name CA 19-9. The D grade applies to screening this population by any method, not to CA 19-9 as a separately graded test. It does not apply to people at high risk because of an inherited genetic syndrome or familial pancreatic cancer.
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a fasting plasma glucose test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Selective (grade C)The USPSTF says the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one for men aged 55 to 69 years. (2018; an update is in progress) · USPSTF ↗ Note: The recommendation states evidence is insufficient that using a prebiopsy risk calculator, with or without free PSA, meaningfully changes the benefits and harms of screening; the USPSTF does not grade free PSA separately, so this file shows the PSA-screening grades. The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against PSA-based screening for prostate cancer in men 70 years or older. (2018; an update is in progress) · USPSTF ↗ Note: The recommendation states evidence is insufficient that using a prebiopsy risk calculator, with or without free PSA, meaningfully changes the benefits and harms of screening; the USPSTF does not grade free PSA separately, so this file shows the PSA-screening grades. The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a hemoglobin A1c test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Recommended (grade A/B)The USPSTF recommends screening for hepatitis B virus infection, with an HBsAg test followed by confirmatory testing, in adolescents and adults at increased risk for infection. (2020) · USPSTF ↗ Note: Risk groups include people born in a country with HBV prevalence of 2% or more, US-born people not vaccinated as infants whose parents were born in regions with very high HBV prevalence (8% or more), people with HIV, people who inject drugs, men who have sex with men, and household or sexual contacts of someone with HBV. The recommendation names regions by prevalence, not countries.
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Recommended (grade A/B)The USPSTF recommends that clinicians offer or refer adults with a body mass index of 30 or higher to intensive, multicomponent behavioral weight-loss interventions. (2018; an update is in progress) · USPSTF ↗ Note: The grade applies to offering or referring adults with a BMI of 30 or higher to intensive behavioral weight-loss programs, not to measuring height, weight or BMI; the USPSTF says screening for obesity is now part of routine clinical practice and was not a focus of its review. The USPSTF lists an update in progress, folded into a combined topic on healthy diet, physical activity and weight loss to prevent cardiovascular disease; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening for pancreatic cancer in asymptomatic average-risk adults. (2019) · USPSTF ↗ Note: The USPSTF does not recommend screening the general population for pancreatic cancer by any method; it mentions MRI only as one of the imaging methods studied in people at high risk. The D grade covers the pancreatic-cancer part of an abdominal MRI only, not the liver or bile duct parts of the scan. It does not apply to people at high risk because of an inherited genetic syndrome or familial pancreatic cancer.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women younger than 21 years. (2018; an update is in progress) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (CIN 2 or 3) or cervical cancer. (2018; an update is in progress) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for cervical cancer every 3 years with cervical cytology alone in women aged 21 to 29 years. (2018; an update is in progress) · USPSTF ↗ Note: A draft update was posted December 10, 2024 (public comment to January 13, 2025); not yet a new final recommendation as of 2026-09-25.
Recommended (grade A/B)The USPSTF recommends screening for cervical cancer in women aged 30 to 65 years, every 3 years with cytology alone, every 5 years with high-risk HPV testing alone, or every 5 years with HPV testing combined with cytology. (2018; an update is in progress) · USPSTF ↗ Note: A draft update was posted December 10, 2024 (public comment to January 13, 2025); not yet a new final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women older than 65 years who have had adequate prior negative screening and are not otherwise at high risk. (2018; an update is in progress) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with transvaginal ultrasound. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers pelvic/transvaginal ultrasound and the CA-125 blood test; see ca125. This csv does not map pelvic_ultrasound to any recommendation about non-ovarian pelvic findings (fibroids, cysts), which the USPSTF does not address.
Selective (grade C)The USPSTF says the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one for men aged 55 to 69 years. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against PSA-based screening for prostate cancer in men 70 years or older. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening with resting or exercise ECG to prevent cardiovascular disease events in asymptomatic adults at low risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening with resting or exercise ECG to prevent cardiovascular disease events in adults at intermediate or high risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for atrial fibrillation with ECG in adults 50 years or older. (2022) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for thyroid cancer in asymptomatic adults. (2017) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for bladder cancer in asymptomatic adults. (2011) · USPSTF ↗ Note: The USPSTF lists urine dipstick or microscopic urinalysis for hematuria (blood in the urine) among the bladder cancer screening tests it considered. This note covers only that use of a urinalysis.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for vitamin D deficiency in asymptomatic adults. (2021) · USPSTF ↗
General preparation notes for 16 tests in this package

This is general information about how the exam is usually done, not medical advice for you or your family member. Requirements vary by center and by individual health history — always follow the center's own instructions and your own doctor's guidance, especially for any medicine change.

Body composition analysis

Mention when booking: Mention a pacemaker or implanted defibrillator: the test passes a weak electric current through the body and has traditionally not been recommended with these devices.

Total cholesterol

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested, so the test is often done in the morning.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Triglycerides

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Fasting glucose

Usually needs at least 8 hours without food or drink except water beforehand.

Mention when booking: If you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting, and mention it to the center.

Urinalysis

Usually needs a clean-catch (midstream) sample; some tests instead ask you to collect all urine passed over 24 hours.

Mention when booking: Ask which specific urine test your provider ordered, since collection instructions vary by test.

Chest X-ray

Usually needs no fasting; you remove jewelry, metal objects and sometimes clothing above the waist for a hospital gown.

Mention when booking: Tell the center if you are, or might be, pregnant.

Abdominal ultrasound

Usually needs about 6 hours without food beforehand; clear fluids other than milk or fizzy drinks are commonly still allowed. Loose, comfortable clothing is easiest.

Mention when booking: Mention if you have type 1 diabetes, so the center can offer an early appointment time.

Kidney and bladder ultrasound

Usually needs little preparation; you may be asked to drink water beforehand to fill the bladder for a clearer view.

Mention when booking: Mention if holding a full bladder is uncomfortable for you; the technologist can adjust timing.

Pelvic (gynecologic) ultrasound

For a transabdominal scan, drinking water beforehand to fill the bladder is common; for a transvaginal scan, an empty bladder is usual instead.

Mention when booking: Tell the center which type of scan you expect, and mention if you are, or might be, pregnant.

Prostate ultrasound

Usually needs little or no preparation; an enema and antibiotics are mainly for a planned biopsy. A scan through the lower belly instead may need a full bladder.

Mention when booking: Mention aspirin or other blood thinners; if a biopsy is planned, the center may ask about pausing them, so ask the prescribing doctor before changing any medicine.

Chest CT (standard dose)

Usually needs a few hours without food or drink if contrast is planned; otherwise little preparation is needed. Loose clothing and no jewelry.

Mention when booking: Tell the center about kidney disease, contrast allergy, diabetes medicine and possible pregnancy; ask the prescribing doctor before changing any medicine.

Abdominal MRI / MRCP

Guidelines on eating vary by center; some ask for a short fast before an abdominal MRI or MRCP. Expect to hold your breath at times during the scan.

Mention when booking: Mention a pacemaker or other implanted device, metal fragments, pregnancy, kidney disease, or claustrophobia.

Afterwards: If you take a sedative for claustrophobia or anxiety, you'll need someone to take you home; arrange this before the scan.

Brain MRI

Guidelines on eating and drinking vary by center, so ask when booking. Remove jewelry and metal beforehand.

Mention when booking: Mention a pacemaker, aneurysm clip, cochlear implant or other implanted device, metal fragments, pregnancy, kidney disease, or claustrophobia.

Afterwards: If you take a sedative for claustrophobia or anxiety, you'll need someone to take you home; arrange this before the scan.

Pap smear

Usually asks that you avoid intercourse, douching and tampons for 24 hours beforehand, and avoid scheduling during your period if possible.

Mention when booking: Tell the center if you are having unexpected bleeding, think you might be pregnant, or have had an abnormal Pap or positive HPV test before.

Afterwards: Light bleeding or spotting afterward is common and usually stops within a few hours.

Bone density (DXA)

Usually asks that you skip calcium supplements for 24 hours beforehand. Avoid clothing with metal zippers or buttons, and remove jewelry.

Mention when booking: Mention any recent barium exam or CT/nuclear-medicine contrast, and whether pregnancy is possible.

Hearing test

Usually needs no special preparation; expect to listen for tones or words through headphones, and sometimes a small probe checks how the eardrum moves.

Sources
As published by the hospital · checked 2026-09-20

How we collect and check these prices: see who we are and where the data comes from.

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.
IMS-5 Checkup
US$2,430
Book this checkup

If this isn't quite right

Other packages at Mackay Memorial Hospital

PackageTestsPrice
IMS-1 Checkup41
US$561
NT$18,000
IMS-2 Checkup48
US$872
NT$28,000
IMS-3 Checkup62
US$1,184
NT$38,000
IMS-4 Checkup64
US$1,807
NT$58,000
IMS-6 Checkup71
US$3,364
NT$108,000

All packages at Mackay Memorial Hospital Health Examination Center →

Similar packages in Taipei

All checkups in Taipei →

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.

Browse: Brain · Cancer screening · All checkups in Taipei · What a checkup costs in Taiwan